Southpoint Capital Advisors Lp - Net Worth and Insider Trading
Southpoint Capital Advisors Lp Net Worth
The estimated net worth of Southpoint Capital Advisors Lp is at least $31 Million dollars as of 2024-05-15. Southpoint Capital Advisors Lp is the 10% Owner of Fennec Pharmaceuticals Inc and owns about 4,077,214 shares of Fennec Pharmaceuticals Inc (FENC) stock worth over $30 Million. Southpoint Capital Advisors Lp is also the 10% Owner of Amarin Corp PLC and owns about 821,633 shares of Amarin Corp PLC (AMRN) stock worth over $747,522. Details can be seen in Southpoint Capital Advisors Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Southpoint Capital Advisors Lp has not made any transactions after 2020-05-04 and currently still holds the listed stock(s).
Transaction Summary of Southpoint Capital Advisors Lp
Southpoint Capital Advisors Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Southpoint Capital Advisors Lp owns 4 companies in total, including Fennec Pharmaceuticals Inc (FENC) , Lisata Therapeutics Inc (LSTA) , and Seelos Therapeutics Inc (SEEL) among others .
Click here to see the complete history of Southpoint Capital Advisors Lp’s form 4 insider trades.
Insider Ownership Summary of Southpoint Capital Advisors Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc | 2020-05-04 | 10 percent owner |
| LSTA | Lisata Therapeutics Inc | 2007-08-09 | 10 percent owner |
| SEEL | Seelos Therapeutics Inc | 2006-12-21 | 10 percent owner |
 | | 2007-01-03 | other: Reporting Person |
Southpoint Capital Advisors Lp Latest Holdings Summary
Southpoint Capital Advisors Lp currently owns a total of 2 stocks. Among these stocks, Southpoint Capital Advisors Lp owns 4,077,214 shares of Fennec Pharmaceuticals Inc (FENC) as of May 4, 2020, with a value of $30 Million and a weighting of 97.56%. Southpoint Capital Advisors Lp also owns 821,633 shares of Amarin Corp PLC (AMRN) as of April 20, 2006, with a value of $747,522 and a weighting of 2.44%.
Latest Holdings of Southpoint Capital Advisors Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc | 2020-05-04 | 4,077,214 | 7.34 | 29,926,751 |
| AMRN | Amarin Corp PLC | 2006-04-20 | 821,633 | 0.91 | 747,522 |
Holding Weightings of Southpoint Capital Advisors Lp
Southpoint Capital Advisors Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Southpoint Capital Advisors Lp has made a total of 1 transactions in Fennec Pharmaceuticals Inc (FENC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 80,000 shares on May 4, 2020, which cost Southpoint Capital Advisors Lp around $500,000.
According to the SEC Form 4 filings, Southpoint Capital Advisors Lp has made a total of 0 transactions in Amarin Corp PLC (AMRN) over the past 5 years. The most-recent trade in Amarin Corp PLC is the sale of 0 shares on April 20, 2006, which brought Southpoint Capital Advisors Lp around $0.
Insider Trading History of Southpoint Capital Advisors Lp
- 1
Southpoint Capital Advisors Lp Trading Performance
GuruFocus tracks the stock performance after each of Southpoint Capital Advisors Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Southpoint Capital Advisors Lp is 38.25%. GuruFocus also compares Southpoint Capital Advisors Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Southpoint Capital Advisors Lp within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Southpoint Capital Advisors Lp's insider trading performs compared to the benchmark.
Performance of Southpoint Capital Advisors Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.98 | | | | | |
| Relative Return to S&P 500(%) | 6.5 | | | | | |
Southpoint Capital Advisors Lp Ownership Network
Southpoint Capital Advisors Lp Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Southpoint Capital Advisors Lp is the 10 percent owner of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include director & Chief Executive Officer Rosty Raykov , Chief Financial Officer Robert Andrade , and Chief Commercial Officer Shubh Goel .
Fennec Pharmaceuticals Inc (FENC) Insider Trades Summary
Over the past 18 months, Southpoint Capital Advisors Lp made no insider transaction in Fennec Pharmaceuticals Inc (FENC). Other recent insider transactions involving Fennec Pharmaceuticals Inc (FENC) include a net sale of 16,340 shares made by Chris A Rallis , a net sale of 189,038 shares made by Rosty Raykov , and a net sale of 104,950 shares made by Robert Andrade .
In summary, during the past 3 months, insiders sold 384,683 shares of Fennec Pharmaceuticals Inc (FENC) in total and bought 0 shares, with a net sale of 384,683 shares. During the past 18 months, 532,549 shares of Fennec Pharmaceuticals Inc (FENC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 532,549 shares.
Fennec Pharmaceuticals Inc (FENC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Southpoint Capital Advisors Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Southpoint Capital Advisors Lp. You might contact Southpoint Capital Advisors Lp via mailing address: 1114 Avenue Of The Americas, 22nd Floor, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
